Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg inthe United States. Mayne Pharma received approval from the US Food and Drug Administration for its Abb...